Cytarabine Patent Expiration
Cytarabine is used for treating lymphomatous meningitis via intrathecal administration. It was first introduced by Teva Parenteral Medicines Inc
Cytarabine Patents
Given below is the list of patents protecting Cytarabine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Depocyt | US5723147 | Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride |
Mar 03, 2015
(Expired) | Pacira Pharms Inc |
| Depocyt | US5455044 | Method for treating neurological disorders |
May 14, 2013
(Expired) | Pacira Pharms Inc |
Cytarabine's Family Patents
Explore Our Curated Drug Screens
Cytarabine Generic API Manufacturers
Several generic applications have been filed for Cytarabine. The first generic version for Cytarabine was by Hikma Pharmaceuticals Usa Inc and was approved on Aug 2, 1989. And the latest generic version is by Meitheal Pharmaceuticals Inc and was approved on Feb 28, 2022.
Given below is the list of companies who have filed for Cytarabine generic, along with the locations of their manufacturing plants worldwide.
1. FRESENIUS KABI USA
Fresenius Kabi Usa Llc has filed for 1 generic for Cytarabine. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/ML
(reference standard) | injectable | Prescription | INJECTION | AP | Jan 15, 2004 |
Manufacturing Plant Locations New
Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
2. GLAND PHARMA LTD
Gland Pharma Ltd has filed for 2 different strengths of generic version for Cytarabine. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/VIAL | injectable | Prescription | INJECTION | AP | Dec 23, 2019 |
| 2GM/VIAL | injectable | Prescription | INJECTION | AP | Dec 23, 2019 |
3. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Cytarabine. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/VIAL | injectable | Prescription | INJECTION | AP | Aug 2, 1989 |
| 500MG/VIAL
(reference standard) | injectable | Prescription | INJECTION | N/A | Aug 2, 1989 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| Portugal |
| |||||||||
| Jordan |
| |||||||||
4. HOSPIRA
Hospira Inc has filed for 2 different strengths of generic version for Cytarabine. Given below are the details of the strengths of this generic introduced by Hospira.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG/ML
(reference standard) | injectable | Prescription | INJECTION | AP | Feb 28, 1994 |
| 100MG/ML | injectable | Prescription | INJECTION | AP | Nov 22, 1999 |
Manufacturing Plant Locations New
Hospira's manufacturing plants are situated in 3 countries - Australia, United States, Dominican Republic (the). Given below are the details of these plant locations as well as the firm names of Hospira as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Australia |
| |||||||||||||
| United States |
| |||||||||||||
| Dominican Republic (the) |
| |||||||||||||
5. MEITHEAL
Meitheal Pharmaceuticals Inc has filed for 2 different strengths of generic version for Cytarabine. Given below are the details of the strengths of this generic introduced by Meitheal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG/ML | injectable | Prescription | INJECTION | AP | Feb 28, 2022 |
| 100MG/ML | injectable | Prescription | INJECTION | AP | Jul 17, 2018 |
6. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 1 generic for Cytarabine. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG/ML | injectable | Discontinued | INJECTION | N/A | Dec 13, 2011 |
7. RISING
Rising Pharma Holding Inc has filed for 2 different strengths of generic version for Cytarabine. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG/ML | injectable | Prescription | INJECTION | AP | Dec 13, 2011 |
| 100MG/ML | injectable | Prescription | INJECTION | AP | Jan 30, 2012 |
Manufacturing Plant Locations New
Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||
| Mexico |
| |||||||||||||||||||
| India |
| |||||||||||||||||||
8. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 4 different strengths of generic version for Cytarabine. All of these versions come by the name CYTOSAR-U. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2GM/VIAL | injectable | Discontinued | INJECTION | N/A | Dec 30, 1998 |
| 100MG/VIAL | injectable | Discontinued | INJECTION | N/A | Dec 30, 1998 |
| 500MG/VIAL | injectable | Discontinued | INJECTION | N/A | Dec 30, 1998 |
| 1GM/VIAL | injectable | Discontinued | INJECTION | N/A | Dec 30, 1998 |
9. WEST-WARD PHARMS INT
West-ward Pharmaceuticals International Ltd has filed for 2 different strengths of generic version for Cytarabine. Given below are the details of the strengths of this generic introduced by West-ward Pharms Int.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1GM/VIAL
(reference standard) | injectable | Prescription | INJECTION | N/A | Aug 31, 1994 |
| 2GM/VIAL
(reference standard) | injectable | Prescription | INJECTION | AP | Aug 31, 1994 |